Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunocompromised Host”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Not applicableStudy completedNCT03378947
What this trial is testing

EBV-associated Diffuse Large B Cell Lymphoma

Who this might be right for
To Characterize and Compare Clinical, Pathological and Molecular Features
Hospices Civils de Lyon 70
Early research (Phase 1)Looking for participantsNCT05141058
What this trial is testing

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

Who this might be right for
SARS-CoV-2 Infection
Children's National Research Institute 24
Not applicableLooking for participantsNCT07321808
What this trial is testing

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine (RZV) in Frail Patients: Multicentric Prospective Study

Who this might be right for
Immunocompromised Patients
Fondazione IRCCS Policlinico San Matteo di Pavia 300
Testing effectiveness (Phase 2)Ended earlyNCT03334240
What this trial is testing

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

Who this might be right for
HPV-Induced Genital Lesions
Maruho Co., Ltd. 28
Not applicableUnknownNCT02104479
What this trial is testing

Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing

Who this might be right for
Invasive AspergillosisPleural EffusionImmunosuppression
Heidelberg University 200
Testing effectiveness (Phase 2)Study completedNCT04895982
What this trial is testing

Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

Who this might be right for
SARS-CoV-2 Infection, COVID19
BioNTech SE 124
Not applicableNot Yet RecruitingNCT06387667
What this trial is testing

Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections

Who this might be right for
Immunocompromised ICU Patients With Respiratory Tract Infections
New Valley University 250
Not applicableAvailableNCT05844436
What this trial is testing

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

Who this might be right for
HSV
AiCuris Anti-infective Cures AG
Post-approval studies (Phase 4)Looking for participantsNCT05439083
What this trial is testing

Immunogenicity of 9-valent HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Talia Sainz Costa 120
Post-approval studies (Phase 4)Study completedNCT01935531
What this trial is testing

Effects of Topical Diclofenac on Tumor Metabolism

Who this might be right for
Actinic Keratoses
University Hospital Regensburg 38
Large-scale testing (Phase 3)Study completedNCT03073967
What this trial is testing

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Who this might be right for
HSV Infection
AiCuris Anti-infective Cures AG 158
Post-approval studies (Phase 4)Study completedNCT01109914
What this trial is testing

Mucosal Response in Immunocompromised Host

Who this might be right for
Kidney TransplantationImmunity
Leiden University Medical Center 51
Post-approval studies (Phase 4)Ended earlyNCT04673175
What this trial is testing

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Who this might be right for
PneumoniaHematologic MalignancyPseudomonas Aeruginosa Infection+2 more
Weill Medical College of Cornell University 17
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Large-scale testing (Phase 3)Study completedNCT01229267
What this trial is testing

Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 1,257
Testing effectiveness (Phase 2)Study completedNCT04969601
What this trial is testing

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)Study completedNCT05210101
What this trial is testing

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Who this might be right for
SARS CoV 2 Infection
Sophia Koo, M.D. 93
Not applicableUnknownNCT01695512
What this trial is testing

Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients

Who this might be right for
Invasive AspergillosisAcute LeukemiaBiomarkers+1 more
Heidelberg University 200
Large-scale testing (Phase 3)Looking for participantsNCT03656081
What this trial is testing

Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole

Who this might be right for
Chronic Pulmonary Aspergillosis
Poitiers University Hospital 224
Early research (Phase 1)Looking for participantsNCT04691622
What this trial is testing

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Who this might be right for
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute 48
Load More Results